The Advisory Committee on Immunization Practices (ACIP) has revised its vaccination schedule for HPV vaccination among younger populations. ACIP says those starting vaccination between ages 9 and 14 can now get just two doses of HPV vaccine rather than three, with the second dose administered 6 to 12 months after the first dose. Three doses remains the recommendation for those 15 and over and for immunocompromised persons. Previously, ACIP recommended all age groups get three doses of the vaccine, with the second dose administered 1 to 2 months after the first, and the third dose administered 6 months after the first dose.
We asked Debbie Saslow, PhD, Senior Director, HPV Related and Women’s Cancers about the change.
The ACIP’s action to revise its recommendation sets in motion the ACS process to review and update its own guideline, which currently closely mirrors the previous ACIP recommendation and emphasizes the need for on-time vaccination, i.e. at age 11-12, when vaccination is most effective.
Read more about HPV vaccines here.